Ann Arbor pharmaceutical company Esperion Therapeutics rings Nasdaq … – AnnArbor.com
|
Ann Arbor pharmaceutical company Esperion Therapeutics rings Nasdaq …
AnnArbor.com Esperion Theraputics executives Tim Mayleben and Roger Newton rang the bell to open trading on the Nasdaq exchange Wednesday morning. Esperion returned to the exchange June 26 through a second “initial” public offering. Pfizer purchased the original … |
